Company Filing History:
Years Active: 2017-2019
Title: Veejendra K Yadav: Innovator in Kynurenine Pathway Research
Introduction
Veejendra K Yadav is a notable inventor based in Kanpur, India. He has made significant contributions to the field of biochemistry, particularly in the development of inhibitors targeting the kynurenine pathway. With a total of two patents to his name, his work is paving the way for new therapeutic approaches.
Latest Patents
Yadav's latest patents focus on novel inhibitors of indoleamine 2,3-dioxygenase-1, indoleamine 2,3-dioxygenase-2, and tryptophan 2,3-dioxygenase. These compounds, along with their metabolites and pharmaceutically acceptable salts or prodrugs, are designed to treat diseases resulting from dysregulation of the kynurenine pathway. The compounds act by inhibiting the enzymatic activity or expression of the aforementioned enzymes, showcasing their potential in therapeutic applications.
Career Highlights
Throughout his career, Yadav has worked with Curadev Pharma Pvt Ltd and Curadev Pharma Private Limited. His experience in these companies has allowed him to collaborate with other professionals in the field and contribute to innovative research.
Collaborations
Some of his notable coworkers include Monali Banerjee and Sandip Middya. Their collaborative efforts have further advanced the research and development of new therapeutic compounds.
Conclusion
Veejendra K Yadav's work in the field of kynurenine pathway inhibitors represents a significant advancement in biochemistry and therapeutic development. His contributions are likely to have a lasting impact on the treatment of related diseases.